Armor Medical’s Wearable Could Give Earlier Warnings of Severe He...

Why It Matters

Armor Medical’s early‑warning wearable could dramatically improve patient outcomes, while the expanding MedTech Innovator ecosystem and rising IPO activity signal stronger funding pipelines for next‑generation health technologies.

Key Takeaways

• Armor Medical won MedTech Innovator grand prize for wearable sensor.
• Wearable aims to provide early warnings of severe health events.
• 1,830 companies applied to MedTech Innovator, 23% increase year‑over‑year.
• Radar Forum will host 180 startups with industry decision‑makers.
• Surge in medtech IPOs signals stronger capital flow for innovators.

Summary

The episode centers on Armor Medical’s breakthrough wearable, which earned the company the grand prize at the MedTech Innovator competition. Host Tom Salmi interviews CEO Kelsey Mayo, highlighting how the sensor could alert patients and clinicians to impending severe health crises far earlier than current methods. Key data points include a record 1,830 applications to MedTech Innovator—a 23% jump from the prior cycle—and the upcoming Radar Forum, where roughly 180 top‑stage startups will be evaluated by a curated mix of investors, regulators, and health‑system leaders. The forum’s collaborative diligence format promises real‑time feedback that could accelerate funding and adoption. Paul Grant’s remarks underscore the industry’s shift toward collective vetting: “We sit around the table with the who’s‑who of medtech, debating and refining each pitch.” Mayo’s excitement about the wearable’s potential is echoed by the broader community, which sees early‑warning devices as a new frontier for patient safety. For stakeholders, the win signals a viable path from accelerator to market, while the surge in medtech IPOs—exemplified by companies like Medtronic—suggests a healthier capital environment. Investors and health systems should monitor Armor Medical and similar innovators as they move toward commercialization, potentially reshaping chronic‑care monitoring and reducing emergency interventions.

Original Description

In this episode, Armor Medical Co-founder and CEO Kelsey Mayo shares her ultimate entrepreneurial journey. Mayo recognized early on that her career needed to make an impact, but the focus of her passion became clear after a frightening experience of her own. Today, she’s CEO of a startup building a wearable device that can serve as an early warning system for hemorrhaging. This could immediately protect the lives of women giving birth and ultimately replace guesswork with irrefutable data. Armor Medical won MedTech Innovator’s top award at AdvaMed in the fall.

This episode is sponsored by DeviceTalks Minnesota.

Speaking of MedTech Innovator, CEO Paul Grand joins Tom Salemi and Chris Newmarker to analyze this week’s top Newsmakers from MassDevice — DePuy Synthes, Medtronic, Pharaoh Neuro, Stryker, and Boston Scientific.

Grand also introduced MedTech Innovator’s Radar Forum:

https://medtechinnovator.org/radarforum2026/

***

Enjoy the show? Follow [DeviceTalks Weekly](https://devicetalksweekly.castos.com/subscribe) on all major podcast players + Follow us on YouTube.com/@DeviceTalks to ensure you never miss an episode.

Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe

00:03:30 MedTech Innovator Radar Forum

00:12:06 Pharaoh Neuro raises $20M, names former Medtronic exec as CEO

00:15:05 Medtronic MiniMed Diabetes unit prices IPO at up to $784M

00:20:40 Medtronic wins CE mark for next-gen GI Genius module, ColonPRO software

00:22:50 AHA, ACC issue guidelines for pulmonary embolism that affect Boston Scientific, Stryker

00:24:56 Johnson & Johnson MedTech reportedly eyes $20B deal to sell DePuy Synthes ortho unit

00:34:13 Keynote interview: Kelsey Mayo, Co-founder and CEO, Armor Medical